Venturi Wealth Management LLC Has $59,000 Stock Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

Venturi Wealth Management LLC boosted its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 1,510.0% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 322 shares of the medical instruments supplier’s stock after acquiring an additional 302 shares during the quarter. Venturi Wealth Management LLC’s holdings in ICU Medical were worth $59,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. SG Americas Securities LLC raised its stake in shares of ICU Medical by 441.7% during the second quarter. SG Americas Securities LLC now owns 5,818 shares of the medical instruments supplier’s stock worth $691,000 after buying an additional 4,744 shares during the last quarter. Sei Investments Co. boosted its stake in ICU Medical by 52.1% in the 1st quarter. Sei Investments Co. now owns 28,586 shares of the medical instruments supplier’s stock worth $3,068,000 after purchasing an additional 9,793 shares during the period. Silvercrest Asset Management Group LLC grew its holdings in shares of ICU Medical by 109.4% during the first quarter. Silvercrest Asset Management Group LLC now owns 278,436 shares of the medical instruments supplier’s stock worth $29,882,000 after buying an additional 145,485 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of ICU Medical by 0.5% during the 1st quarter. Vanguard Group Inc. now owns 2,452,720 shares of the medical instruments supplier’s stock worth $263,226,000 after acquiring an additional 11,991 shares in the last quarter. Finally, Savant Capital LLC acquired a new stake in ICU Medical in the 2nd quarter valued at $431,000. Institutional investors own 96.10% of the company’s stock.

Analyst Upgrades and Downgrades

ICUI has been the topic of several analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of ICU Medical in a research report on Wednesday. Jefferies Financial Group initiated coverage on ICU Medical in a report on Monday, October 14th. They issued a “hold” rating and a $183.00 price objective on the stock. StockNews.com downgraded shares of ICU Medical from a “buy” rating to a “hold” rating in a research report on Tuesday. Raymond James upped their price objective on shares of ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research report on Thursday, September 12th. Finally, KeyCorp lifted their price target on ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research note on Wednesday. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, ICU Medical has an average rating of “Moderate Buy” and a consensus price target of $173.00.

Insider Activity

In other ICU Medical news, CEO Vivek Jain sold 12,000 shares of the company’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $178.46, for a total value of $2,141,520.00. Following the transaction, the chief executive officer now directly owns 104,593 shares in the company, valued at $18,665,666.78. This represents a 10.29 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Daniel Woolson sold 2,502 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $163.22, for a total transaction of $408,376.44. Following the completion of the transaction, the vice president now owns 13,107 shares in the company, valued at approximately $2,139,324.54. This trade represents a 16.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 38,502 shares of company stock worth $6,573,496. 6.70% of the stock is owned by corporate insiders.

ICU Medical Price Performance

Shares of NASDAQ:ICUI opened at $167.86 on Friday. ICU Medical, Inc. has a fifty-two week low of $82.82 and a fifty-two week high of $196.26. The company’s 50-day moving average is $176.43 and its 200 day moving average is $142.68. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.08 and a current ratio of 2.29. The company has a market capitalization of $4.11 billion, a P/E ratio of -36.73 and a beta of 0.66.

ICU Medical (NASDAQ:ICUI) last released its earnings results on Tuesday, November 12th. The medical instruments supplier reported $1.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.88 by $0.35. The business had revenue of $580.07 million during the quarter, compared to the consensus estimate of $574.77 million. ICU Medical had a positive return on equity of 5.05% and a negative net margin of 4.74%. On average, equities research analysts forecast that ICU Medical, Inc. will post 3.81 earnings per share for the current year.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.